Avedro is a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses. Avedro’s proprietary Avedro Corneal Remodeling Platform strengthens, stabilizes and reshapes the cornea utilizing corneal cross-linking in minimally invasive and non-invasive outpatient procedures to treat corneal ectatic disorders and correct refractive conditions. The Avedro Corneal Remodeling Platform is comprised of Avedro’s KXL and Mosaic systems, each of which delivers ultraviolet A light, and a suite of proprietary single-use riboflavin drug formulations, which, when applied together to the cornea, induce a biochemical reaction called corneal collagen cross-linking.
Looking for a particular Avedro, Inc. employee's phone or email?
The Avedro, Inc. annual revenue was $10.6 million in 2026.
15 people are employed at Avedro, Inc..
Avedro, Inc. is based in Waltham, Massachusetts.
The NAICS codes for Avedro, Inc. are [54, 3254, 5417, 325, 541, 32541, 32].
The SIC codes for Avedro, Inc. are [38, 382].